|
|
Innovation Agenda
Presentation slides, when available, will be linked from the session title.
CNE Credit 5.5*
This continuing nursing education activity was approved by the Northeast Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
| Time | Activity / Session | Location |
| 7:15 - 9:00 AM | Registration | Foyer |
| 7:30 - 8:55 AM | Breakfast (available 7:15-8:45am), Exhibits, Poster Session | Ballroom |
| 7:30 - 8:55 AM |
Patient Assistance / Advocacy Presentation Breakfast | Concord |
| 8:55 - 9:00 AM |
Welcoming Remarks
Nicole Messier BSN, RN, OCN, ONN-CG, NAHPAC Co- Chair
Christian A. Thomas, MD - NNECOS President
|
State Rooms (Webster & Pierce) |
| 9:00 - 9:45 AM | Survivorship in Advanced Disease Susan Gruber |
State Rooms (Webster & Pierce) |
| 9:45 - 10:15 AM |
Biosimilars 101: How “similar” are they? Matthew Marston, Pharm.D., BCPS, BCOP |
State Rooms (Webster & Pierce) |
| 10:15 - 10:45 AM | Refreshment / Exhibit Break / Posters |
Foyer & Ballroom |
| 10:45 - 11:45 AM |
Janet R Ely, MSN, FNP, AOCNP, APCHN
Diane Koeller, MS, MPH, LGC Jennifer May, RD, CD Nicole Messier BSN, RN, OCN, ONN-CG Tumor board format presentation/discussion of a difficult patient case. |
State Rooms (Webster & Pierce) |
| 11:50 AM - 12:30 PM | ASCO Update: Oncology Care in the Current Administration Amanda Schwartz, MPS Director, Congressional Affairs at ASCO A high level overview of ASCO’s policy setting and priorities. The presentation will include discussion of ASCO’s federal and state legislative activity as well as regulatory work with the Administration. Further, the speaker will address how attendees can get involved in advocacy on behalf of cancer care and research. Topics address will include; MACRA implementation, 340B, opioids, and federal funding for research. |
State Rooms (Webster & Pierce) |
| 12:30 - 1:30 PM | Lunch / Exhibits / Posters |
Ballroom |
| 1:30 - 2:30 PM |
2017-2018 Drug Updates in Hematology/Oncology Laura J. Hackett, PharmD, BCOP Learn about new hematology/oncology agents granted FDA-approval in 2017-2018. This session will address genomic drug naming formulas, differentiate biosimilars from generic drugs, and define gene therapy. |
State Rooms (Webster & Pierce) |
| 2:35 PM - 3:30 PM |
Innovative Abstracts Podium Presentation
|
State Rooms (Webster & Pierce) |
| 3:35 - 4:15 PM |
Genetics 101: Clinical Cancer Genetics Diane Koeller, MS, MPH, LGC Dana-Farber Cancer Institute This talk will review the basics of cancer genetics, including sporadic versus hereditary cancers, somatic versus germline genetic mutations, common hereditary cancer syndromes, genetics referral guidelines and the impact of cancer genetics on cancer treatment. |
State Rooms (Webster & Pierce) |
| 4:15 - 4:20 PM | Closing Remarks Christian A. Thomas, MD - NNECOS President |
State Rooms (Webster & Pierce) |
| 4:20 - 5:15 PM |
Networking Reception & Prize Drawing
|
Foyer |
Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org
This website brought to you by:
